CENTENE CORPDRNCENTENE CORPDRNCENTENE CORPDRN

CENTENE CORPDRN

No trades
See on Supercharts

Key facts today

Deutsche Bank lowered Centene Corporation's price target to $84 from $87, keeping a hold rating. Analysts report an average overweight rating and a mean price target of $81.25 for Centene Corporation.
Centene Corporation shares rose as investors reacted to concerns over possible Medicaid funding cuts after Dr. Mehmet Oz was nominated to head the Centers for Medicare and Medicaid Services.
Analyze the impactAnalyze the impact
Market capitalization
‪168.80 B‬BRL
31.61BRL
‪13.14 B‬BRL
‪748.66 B‬BRL
‪499.37 M‬
Beta (1Y)
−0.17

About Centene Corporation


CEO
Sarah McGinty London
Headquarters
St. Louis
Founded
1984
ISIN
BRC1NCBDR000
FIGI
BBG00R2CQ5L8
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Performance
Revenue to profit conversion
Insurance reserves, claims and premiums
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
CNC5130037
Centene Corporation 2.5% 01-MAR-2031
Yield to maturity
6.37%
Maturity date
Mar 1, 2031
QENB
CENTENE 21/31
Yield to maturity
6.36%
Maturity date
Aug 1, 2031
US15135BAW1
CENTENE 20/30
Yield to maturity
6.17%
Maturity date
Oct 15, 2030
CNC4947534
Centene Corporation 3.375% 15-FEB-2030
Yield to maturity
6.13%
Maturity date
Feb 15, 2030
CNC4976670
Centene Corporation 4.625% 15-DEC-2029
Yield to maturity
5.93%
Maturity date
Dec 15, 2029
US15135BAY7
CENTENE 21/28
Yield to maturity
5.86%
Maturity date
Jul 15, 2028
CNC4976671
Centene Corporation 4.25% 15-DEC-2027
Yield to maturity
5.57%
Maturity date
Dec 15, 2027
CNC4916042
Centene Corporation 4.25% 15-DEC-2027
Yield to maturity
3.43%
Maturity date
Dec 15, 2027
CNC4947504
Centene Corporation 3.375% 15-FEB-2030
Yield to maturity
3.27%
Maturity date
Feb 15, 2030

Explore more bonds